Claire Bombardier, MD, FRCPC

University of Toronto - Toronto
Toronto, ON, Canada

Claire Bombardier, MD, FRCPC
Senior Scientist, Toronto General Research Institute
Professor of Medicine, University of Toronto
Division of Rheumatology, Mount Sinai Hospital
Dr. Bombardier is a Master of the American College of Rheumatology (ACR) and a Distinguished Clinician-Investigator of the ACR. She was the founding director of the clinical epidemiology program at the University of Toronto and a co-founder of the Institute for Work & Health. She was also the co-scientific director of CAN (Canadian Arthritis Network): a national center of excellence and is the past Director of the University of Toronto Rheumatology Program.
For the last 10 years, her research has focussed on real-world evidence of safety and effectiveness of new drugs. To this effect she created “The Ontario Best Practice Research Initiative (OBRI)” which is a Province wide registry of Ontario patients with rheumatoid arthritis with clinical data linked to ICES.

Disclosure information not submitted.

Presentation(s):

• 1402: Late Onset Rheumatoid Arthritis Has a Similar Remission Rate as Younger Onset Rheumatoid Arthritis: Results from an Ontario Rheumatoid Arthritis Registry

  Sunday, November 13, 2022
  1:00 PM – 3:00 PM Eastern Time